The Big Winner With Johnson & Johnson's Recent FDA Approval

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 23, 2021 at 11:03 AM.

  1. #1 cafead, Jul 23, 2021 at 11:03 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via
    • The FDA recently approved a subcutaneous version of J&J's blood cancer drug Darzalex.
    • This approval probably won't significantly impact J&J overall due to the company's size and potential cannibalization of sales from the current version of Darzalex.
    • J&J's small partner that contributed key technology for the new Darzalex version could be the big winner.

    article source
     
    Quote

Reply to Thread